Menu

FibroGen, Inc. FGEN

Full chart Compare
Set alert

Price alert · FGEN

All alert types
9.07 USD 0.00 (+0.00%)

Jan 12, 2026, 9:30 AM EST

9.02 Day range 9.21

52-week range unavailable

YTD
+3.30%
1 year
-41.90%

Revenue & Expenses

Revenue by
Europe → Revenue: $5.64MOther Income → Gross Profit & Other Income: $234.59MGross Profit & Other Income → Net Income: $183.45MGross Profit & Other Income → Selling, General & Admin: $27.71MGross Profit & Other Income → Research & Development: $23.52MJapan → Revenue: $797.00KIncome Tax Benefit → Gross Profit & Other Income: $90.00KOther Income$234.59MIncome Tax Benefit$90.00KGross Profit & Other Income$234.68MNet Income$183.45MSelling, General & Admin$27.71MResearch & Development$23.52MRevenue$6.44MEurope$5.64MJapan$797.00K

Latest period ending Dec 31, 2024 · select a line to chart its full history

FGEN annual income statement
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
29.62M46.80M140.73M235.31M176.32M
14.06M42.84M120.45M222.44M167.45M
-150.42M-322.72M-301.02M-288.53M-191.88M
-47.58M-284.23M-293.65M-290.02M-189.29M
-12.00-73.00-78.00-78.00-53.00
FGEN annual balance sheet
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
50.48M81.55M155.70M171.22M678.39M
214.53M423.53M610.09M773.82M826.84M
398.16M585.73M611.57M544.71M385.39M
131.96M201.03M139.22M99.72M39.76M
-225.60M-204.17M-21.45M209.15M422.18M
FGEN annual cash flow
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
-138.00M-315.02M-145.93M-82.23M81.60M
125.99M153.66M89.12M-426.97M452.49M
-255.00K122.75M46.78M-563.00K13.34M
780.00K-2.52M-3.73M-5.19M-3.99M
-11.51M-42.01M-15.52M-507.17M552.13M